SlideShare a Scribd company logo
Critical Alerts in Laboratory
Group :1
Dr. Pallavi Shukla Reviewed By :
Dr. Sujith H. Dr. Lallu Joseph
Mr. Govardan Dr. Uma Shankar
Mr. Shankar Hiremat Ms. Jyothi Ramesh
Defining Critical Value
“Values that are outside normal range to a degree that may contribute on immediate health
risk to individual or require immediate action on part of ordering physician”
•Alert value:
These are results that deviate from their reference ranges less
significantly than critical values.
Why is it so Important??
• To prevent imminent life threatening situation
• Help clinicians redefining treatment plans
• Failure to report poses a threat to patient safety and hospital quality
• critical values communication is now an integral part of many accreditation
procedures for medical laboratories like ISO,NABL
• endorsed as one of the leading quality indicators of the post-analytical phase by
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
Upper Limit
Lower Limit Normal Range
Value= 120mmol/L
(potentialharm likely to
occur:cerebraloedema)
Value≤ 115mmol/Lorrapid
reductionin sodium level (may
lead tocomaor death)
SerumSODIUM
135-145 mmol/L
Value>145 mmol/L
(hypernatremia)
Value<135 mmol/L
(hyponatremia)
LOWERCRITICALV
ALUE/RESUL
T UPPERCRITICALV
ALUE/RESUL
T
125
mmol/L
155
mmol/L
Value≥ 158-160mmol?l
(potentialharm likely to
occur:anorexia,muscle
weakness,nausea,vomitting,
lethargy and coma)
Value≥ 160mmol/L
(ass.with 75% mortalityin
adult
ANALYTE CRITICAL VALUE
Haemoglobin Any age ≤7.0 g/dL
Haematocrit (PCV) Any age
≤21.0
≥65.0
%
Potassium;
ISTAT (POCT)
Any age
<3.0
>6.0
mmol/L
pH Any age
<7.20
>7.60
pH units
Bicarbonate (Whole
Blood)
Any age
<10
>40
mEq/L
Troponin I Any age ≥0.3 ng/mL
PT INR Any age >5.0
Clinical Biochemistry and Pathology
Microbiology:
Any Assay with positive bioterrorism agent.
Serology.
Any Clinically Important Positive Culture.
• The Final Classification of a Laboratory result as “Critical” is based on
• It’s Laboratory Values, as well.
• As the Patient’s analytical history and
• Any available Clinical Information.
• Should be Communicated with 1 hour or asap.
• 24X7
Developing a Training Module
• Policy Standard : The critical Laboratory Results should be
intimidated immediately to the concerned personnel
• Objective: To ensure all critical care results that need
immediate attention by the treating clinicians are defined,
documented, communicated in a defined time frame
Pre Requisites
• The Central Lab committee should identify and define
critical results for all the tests performed in the lab in
consensus with clinicians
• The list to be displayed in the lab
• regularly update the list as and when new tests are
added
• Relevant staff should be trained on critical values and
the reporting process
•Implementation Guidelines/Requirements:
Target Personnel:
Qualified lab personnel,
Nursing staff, Doctors
Training frequency: To be part of induction program and
updated during on going training
• Defining and identifying critical care results
• Define and Identify pre analytical/analytical/post analytical errors
prior to communication
• Informing concerned lab consultant
• Confirming Critical result
• Communicating to concerned personnel (verbal/report
dispatch/electronic modes)
• Documentation(specific register and in case files) and
Communication of critical results(for both inhouse and outsourced)
• Performing Mock Drills
• Sepsis (ABG, CBC, RFT, LFT, Cultures)
• Uncontrolled Diabetes Mellitus (Blood sugars, Urine Ketones, ABG,
RFT, Electrolytes)
• Respiratory Failure (ABG)
• Myocardial Infarction (Cardiac Enzymes)
• Viral Fever(Platelet Count)
• Acute Renal Failure (RFT, Electrolytes)
LABORA
TORYPROCEDUREFORNOTIFICA
TIONOF CRITICALRESUL
TS
LABORATORY
PERFORM
TEST(ROUTINE /
URGENT/STAT)
VERIFY THE
RESULT CHECK
RECORD
ANY
CRITICAL
LIMIT?
REFER
CRITICAL
VALUE LIST
DISPATCH A
COPY OF
RESULT TO
WARD/A&E
CHECK FOR
TREND
PHONE
ELECTRONIC
SMS
MANUAL
DISPATCH
DOCUMENT THE
NOTIFICATION
AND RELEVANT
INFORMATION
INTO RECORD
BOOK,LIS OR
STANDARD
NOTIFICATION
STAFF NURSE
SPECIALIST
MO
JM
MA
INFORM
RESULT AND
ASK FOR READ
BACK
FROM
RECORD
BOOK
COMPARE
WITH
PREVIOUS
RESULT
WHAT
TO
INFORM?
INFORMER NAME
DESIGNATION
PATIENT ID
&LOCATION
TEST NAME&RESULT
SAMPLE DATE
&TIME
DIFFERENT
TREND
TO
WHOM?
HOW?
SAME
TREND
REPEAT
TEST
CHECK FOR
COMMON
ANALYTICAL
INTERFERENCE
CHECK FOR PRE-
ANALYTICAL,
ANALYTICAL &POST
ANALYTICAL FACTOR
RECORD:
INFORMER
NAME &
DESIGNATION
PATIENT ID
& WARD NAME
TEST NAME &
RESULT
SAMPLE
DATE & TIME
RECIPIENT
NAME
WARD/CLINIC/A&EPROCEDUREFORNOTIFICA
TIONOFLABORA
TORYCRITICALRESUL
T
IF PATIENT HAS
BEEN
DISCHARGED
RECORD IN
NURSING
NOTES/NURSING
CARE
PLAN/BHT
MEDICAL
ATTENTION
BY DOCTOR
IN-CHARGE
READ BACK
INFORMATION
RECEIVED
RECORD
INFORMATION
RECEIVED
INFORM
DOCTOR
IMMEDIATELY
CONTACT THE
DOCTOR IN
CHARGE
IMMEDIATELY
ATTACH
RESULT IN BHT
IF PATIENT
TRANSFERRED
OUT TO ANOTHER
HOSPITAL/WARD
TO READ BACK:
PATIENT NAME
& ID
TEST NAME &
RESULT
RECEIPIENT OR
SN IN CHARGE
INFORM/FORWARD
TO STAFF IN
ANOTHER WARD
MO/SPECIALIST IN CHARGE
WILL DECIDE:
CALL BACK PATIENT TO
WARD/CLINIC
BRING FORWARD
APPOINTMENT DATE
CALL PATIENT FOR EARLY
APPOINTMENT
THE DOCTOR
HAS TO SIGN ON
THE RESULT
SLIP
WRITE THE
PLAN
MANAGEMENT
IN PATIENT’S
BHT
IN:
STANDARD FORM
PATIENT CASE NOTE
(IMMEDIATELY DONE)
BHT FOR IN-BHT
OTHERS: i.e: STAMP
WHAT TO RECORD?
PATIENT NAME
PATIENT RN,ID
TEST NAME AND
RESULT
SAMPLE TIME
AND DATE
DATE AND TIME
OF NOTIFICATION
NAME OF
INFORMER
WARD STAFF
RECEIVES CRITICAL
RESULT
NOTIFICATION
FROM LAB
VIA:
 VERBALLY(PHONE)
ELECTRONIC ALERT
(THIS)
 MANUAL
DISPATCH OF
RESULT
 SMS
 E-MAIL
RESPONSIBLE STAFF:
STAFF NURSE IN
CHARGE
MEDICAL ASSISTANT
HO
MO
SPECIALIST
QUICK GUIDE
LABORATORY
1) IDENTIFY ANY
CRITICAL RESULT
2) CONFIRM CRITICAL RESULT
CHECK RESULT
CHECK SAMPLE
CHECK QC
VERIFY CRITICAL RESULT
3) CALL WARD
IMMEDIATELY
4) INFORM RESULT
ASK FOR READ BACK
5) RECORD THE
NOTIFICATION
WARD
6) RECEIVE,RECORD AND
READ BACK THE CLR
7) INFORM MO
IMMEDIATELY
8)GET HARD COPY OF
RESULT FROM LAB
9) ATTACH
RESULTS IN BHT
Monitoring
• HCO to define schedule for assessing quality implementation of
guidelines
• Quality standards of the lab
• Regular updating of the tests list
• Can have mock drills and performance indicators to the staff
• Trained staff can be asked to train other untrained personnel
Evidences
• HCO to have an Apex Manual with
1. the list of tests  their standard reference intervals and critical
result values
2. instructions to the concerned personnel on communication and
reporting
Thank you

More Related Content

What's hot

Intrahospital transport
Intrahospital transportIntrahospital transport
Intrahospital transport
Ajit Singh
 
Code Blue
 Code Blue Code Blue
Code Blue
bocalapam123
 
Chapter 13 sterile packaging
Chapter 13  sterile packagingChapter 13  sterile packaging
Chapter 13 sterile packaging
lahcmultimedia
 
Endotracheal tube
Endotracheal tubeEndotracheal tube
Endotracheal tube
Haseeb Manzoor
 
Rapid response team
Rapid response teamRapid response team
Rapid response team
Ahmad Thanin
 
Cardiac monitoring(presentation ) for medical students
Cardiac monitoring(presentation ) for medical studentsCardiac monitoring(presentation ) for medical students
Cardiac monitoring(presentation ) for medical students
NehaNupur8
 
code-blue.pptx
code-blue.pptxcode-blue.pptx
code-blue.pptx
PreetiChouhan6
 
SPILL MANAGEMENT .pptx
SPILL MANAGEMENT .pptxSPILL MANAGEMENT .pptx
SPILL MANAGEMENT .pptx
Suresh Arumugam
 
Cardio pulmonary resuscitation (CPR)
Cardio pulmonary resuscitation (CPR)Cardio pulmonary resuscitation (CPR)
Cardio pulmonary resuscitation (CPR)
Abiola Mubarak Mohammed
 
Spo2 ppt
Spo2 pptSpo2 ppt
Spo2 ppt
Prof Vijayraddi
 
Medical Legal Power Point- Nancy Caroline
Medical Legal Power Point- Nancy CarolineMedical Legal Power Point- Nancy Caroline
Medical Legal Power Point- Nancy Caroline
djorgenmorris
 
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptxALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ScientificPathology3
 
Restrain policy
Restrain policyRestrain policy
Restrain policy
Nikhil Tasgaonkar
 
Quality Management LABORATORY SAFETY AND REGULATIONS
Quality Management LABORATORY SAFETY AND REGULATIONSQuality Management LABORATORY SAFETY AND REGULATIONS
Quality Management LABORATORY SAFETY AND REGULATIONS
Amany Elsayed
 
Code blue
Code blueCode blue
Code blue
wcmc
 
Bio medical waste
Bio medical wasteBio medical waste
Bio medical waste
KAVITA PAL
 
Eo sterilization an overview
Eo sterilization an overviewEo sterilization an overview
Eo sterilization an overview
Jabed Khan
 
Administering enema
Administering enemaAdministering enema
Administering enema
Nursing Path
 
Endotracheal intubation nursing procedure
Endotracheal intubation nursing procedureEndotracheal intubation nursing procedure
Endotracheal intubation nursing procedure
ABHIJIT BHOYAR
 
Bio-medical waste management
Bio-medical waste managementBio-medical waste management
Bio-medical waste management
Amrutha nayaka
 

What's hot (20)

Intrahospital transport
Intrahospital transportIntrahospital transport
Intrahospital transport
 
Code Blue
 Code Blue Code Blue
Code Blue
 
Chapter 13 sterile packaging
Chapter 13  sterile packagingChapter 13  sterile packaging
Chapter 13 sterile packaging
 
Endotracheal tube
Endotracheal tubeEndotracheal tube
Endotracheal tube
 
Rapid response team
Rapid response teamRapid response team
Rapid response team
 
Cardiac monitoring(presentation ) for medical students
Cardiac monitoring(presentation ) for medical studentsCardiac monitoring(presentation ) for medical students
Cardiac monitoring(presentation ) for medical students
 
code-blue.pptx
code-blue.pptxcode-blue.pptx
code-blue.pptx
 
SPILL MANAGEMENT .pptx
SPILL MANAGEMENT .pptxSPILL MANAGEMENT .pptx
SPILL MANAGEMENT .pptx
 
Cardio pulmonary resuscitation (CPR)
Cardio pulmonary resuscitation (CPR)Cardio pulmonary resuscitation (CPR)
Cardio pulmonary resuscitation (CPR)
 
Spo2 ppt
Spo2 pptSpo2 ppt
Spo2 ppt
 
Medical Legal Power Point- Nancy Caroline
Medical Legal Power Point- Nancy CarolineMedical Legal Power Point- Nancy Caroline
Medical Legal Power Point- Nancy Caroline
 
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptxALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
 
Restrain policy
Restrain policyRestrain policy
Restrain policy
 
Quality Management LABORATORY SAFETY AND REGULATIONS
Quality Management LABORATORY SAFETY AND REGULATIONSQuality Management LABORATORY SAFETY AND REGULATIONS
Quality Management LABORATORY SAFETY AND REGULATIONS
 
Code blue
Code blueCode blue
Code blue
 
Bio medical waste
Bio medical wasteBio medical waste
Bio medical waste
 
Eo sterilization an overview
Eo sterilization an overviewEo sterilization an overview
Eo sterilization an overview
 
Administering enema
Administering enemaAdministering enema
Administering enema
 
Endotracheal intubation nursing procedure
Endotracheal intubation nursing procedureEndotracheal intubation nursing procedure
Endotracheal intubation nursing procedure
 
Bio-medical waste management
Bio-medical waste managementBio-medical waste management
Bio-medical waste management
 

Similar to Critical Alert.-2.pdf

Patient flow efficiency techniques in emergency department
Patient flow efficiency techniques in emergency department Patient flow efficiency techniques in emergency department
Patient flow efficiency techniques in emergency department
Manal Elsayed CPPS, CPHQ, CLSSBB, FISQua, DTQM
 
Effective Documentation for Interpreting Radiology Procedures
Effective Documentation for Interpreting Radiology Procedures Effective Documentation for Interpreting Radiology Procedures
Effective Documentation for Interpreting Radiology Procedures
Medical Transcription Service Company
 
David patterson: Continuing development of the community based anticoagulant ...
David patterson: Continuing development of the community based anticoagulant ...David patterson: Continuing development of the community based anticoagulant ...
David patterson: Continuing development of the community based anticoagulant ...
Nuffield Trust
 
Presentationversino41520162halfpastmidnightfinalversion
Presentationversino41520162halfpastmidnightfinalversionPresentationversino41520162halfpastmidnightfinalversion
Presentationversino41520162halfpastmidnightfinalversion
James Nichols
 
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallRx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
OPUNITE
 
Quality in pathology
Quality in pathologyQuality in pathology
Quality in pathology
Sherin Daniel
 
National Patient Safety Goals by UMass Memorial Health Care
National Patient Safety Goals by UMass Memorial Health CareNational Patient Safety Goals by UMass Memorial Health Care
National Patient Safety Goals by UMass Memorial Health Care
Atlantic Training, LLC.
 
ETHICS IN MEDICAL LABORATORY SCIENCES ppt x
ETHICS IN MEDICAL LABORATORY SCIENCES ppt xETHICS IN MEDICAL LABORATORY SCIENCES ppt x
ETHICS IN MEDICAL LABORATORY SCIENCES ppt x
PratyushJoshi13
 
LENAMARIEDAVIS2.docx
LENAMARIEDAVIS2.docxLENAMARIEDAVIS2.docx
LENAMARIEDAVIS2.docx
Lena Davis
 
Evaluation of the Breathlessness Pilots (OPM)
Evaluation of the Breathlessness Pilots (OPM)Evaluation of the Breathlessness Pilots (OPM)
Evaluation of the Breathlessness Pilots (OPM)
NHS Improving Quality
 
Documentation and Reporting
Documentation and ReportingDocumentation and Reporting
Documentation and Reporting
Naveen Kumar Sharma
 
Dr Brent James: quality improvement techniques at the frontline
Dr Brent James: quality improvement techniques at the frontlineDr Brent James: quality improvement techniques at the frontline
Dr Brent James: quality improvement techniques at the frontline
Nuffield Trust
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boards
Madhuri Miriyala
 
Late Phase Presentation
Late Phase PresentationLate Phase Presentation
Late Phase Presentation
David Selkirk
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
Health Quality Ontario (HQO)
 
Clinical Documentation (assignments’ guidelines)
Clinical Documentation (assignments’ guidelines) Clinical Documentation (assignments’ guidelines)
Clinical Documentation (assignments’ guidelines)
Ahmed AlGahtani, RRT
 
StephanieOney Resume1 (1)
StephanieOney Resume1 (1)StephanieOney Resume1 (1)
StephanieOney Resume1 (1)
shadow187
 
Top 10 Risk Management Recommendations
Top 10 Risk Management RecommendationsTop 10 Risk Management Recommendations
Top 10 Risk Management Recommendations
Texas Medical Liability Trust
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
Puneshwar Keshari
 
Presentation 2 [Autosaved] anj (1) (1).pptx
Presentation 2 [Autosaved] anj (1) (1).pptxPresentation 2 [Autosaved] anj (1) (1).pptx
Presentation 2 [Autosaved] anj (1) (1).pptx
Anjali593758
 

Similar to Critical Alert.-2.pdf (20)

Patient flow efficiency techniques in emergency department
Patient flow efficiency techniques in emergency department Patient flow efficiency techniques in emergency department
Patient flow efficiency techniques in emergency department
 
Effective Documentation for Interpreting Radiology Procedures
Effective Documentation for Interpreting Radiology Procedures Effective Documentation for Interpreting Radiology Procedures
Effective Documentation for Interpreting Radiology Procedures
 
David patterson: Continuing development of the community based anticoagulant ...
David patterson: Continuing development of the community based anticoagulant ...David patterson: Continuing development of the community based anticoagulant ...
David patterson: Continuing development of the community based anticoagulant ...
 
Presentationversino41520162halfpastmidnightfinalversion
Presentationversino41520162halfpastmidnightfinalversionPresentationversino41520162halfpastmidnightfinalversion
Presentationversino41520162halfpastmidnightfinalversion
 
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallRx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
 
Quality in pathology
Quality in pathologyQuality in pathology
Quality in pathology
 
National Patient Safety Goals by UMass Memorial Health Care
National Patient Safety Goals by UMass Memorial Health CareNational Patient Safety Goals by UMass Memorial Health Care
National Patient Safety Goals by UMass Memorial Health Care
 
ETHICS IN MEDICAL LABORATORY SCIENCES ppt x
ETHICS IN MEDICAL LABORATORY SCIENCES ppt xETHICS IN MEDICAL LABORATORY SCIENCES ppt x
ETHICS IN MEDICAL LABORATORY SCIENCES ppt x
 
LENAMARIEDAVIS2.docx
LENAMARIEDAVIS2.docxLENAMARIEDAVIS2.docx
LENAMARIEDAVIS2.docx
 
Evaluation of the Breathlessness Pilots (OPM)
Evaluation of the Breathlessness Pilots (OPM)Evaluation of the Breathlessness Pilots (OPM)
Evaluation of the Breathlessness Pilots (OPM)
 
Documentation and Reporting
Documentation and ReportingDocumentation and Reporting
Documentation and Reporting
 
Dr Brent James: quality improvement techniques at the frontline
Dr Brent James: quality improvement techniques at the frontlineDr Brent James: quality improvement techniques at the frontline
Dr Brent James: quality improvement techniques at the frontline
 
Data and safety monitoring boards
Data and safety monitoring boardsData and safety monitoring boards
Data and safety monitoring boards
 
Late Phase Presentation
Late Phase PresentationLate Phase Presentation
Late Phase Presentation
 
U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014U of T Department of Family & Community Medicine PEARLS 2014
U of T Department of Family & Community Medicine PEARLS 2014
 
Clinical Documentation (assignments’ guidelines)
Clinical Documentation (assignments’ guidelines) Clinical Documentation (assignments’ guidelines)
Clinical Documentation (assignments’ guidelines)
 
StephanieOney Resume1 (1)
StephanieOney Resume1 (1)StephanieOney Resume1 (1)
StephanieOney Resume1 (1)
 
Top 10 Risk Management Recommendations
Top 10 Risk Management RecommendationsTop 10 Risk Management Recommendations
Top 10 Risk Management Recommendations
 
Clinical research protocol
Clinical research protocolClinical research protocol
Clinical research protocol
 
Presentation 2 [Autosaved] anj (1) (1).pptx
Presentation 2 [Autosaved] anj (1) (1).pptxPresentation 2 [Autosaved] anj (1) (1).pptx
Presentation 2 [Autosaved] anj (1) (1).pptx
 

More from Monishabasavaraj

1. CODE BLUE MANAGEMNET.pptx
1. CODE BLUE MANAGEMNET.pptx1. CODE BLUE MANAGEMNET.pptx
1. CODE BLUE MANAGEMNET.pptx
Monishabasavaraj
 
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
Monishabasavaraj
 
2. CPR.pptx
2. CPR.pptx2. CPR.pptx
2. CPR.pptx
Monishabasavaraj
 
STAFF PERSONAL RECORD copy.pptx
STAFF PERSONAL RECORD copy.pptxSTAFF PERSONAL RECORD copy.pptx
STAFF PERSONAL RECORD copy.pptx
Monishabasavaraj
 
SURGICAL SAFETY.pptx
SURGICAL SAFETY.pptxSURGICAL SAFETY.pptx
SURGICAL SAFETY.pptx
Monishabasavaraj
 
PREVENTION OF SEXUAL HARRASEMENT.pptx
PREVENTION OF SEXUAL HARRASEMENT.pptxPREVENTION OF SEXUAL HARRASEMENT.pptx
PREVENTION OF SEXUAL HARRASEMENT.pptx
Monishabasavaraj
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptx
Monishabasavaraj
 
VULNERABLE PATIENT.pptx
VULNERABLE PATIENT.pptxVULNERABLE PATIENT.pptx
VULNERABLE PATIENT.pptx
Monishabasavaraj
 
lookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptxlookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptx
Monishabasavaraj
 
PATIENT FEEDBACK.pptx
PATIENT FEEDBACK.pptxPATIENT FEEDBACK.pptx
PATIENT FEEDBACK.pptx
Monishabasavaraj
 
END OF LIFE CARE.pptx
END OF LIFE CARE.pptxEND OF LIFE CARE.pptx
END OF LIFE CARE.pptx
Monishabasavaraj
 
spillmanagement2q-220919041830-73be6d1d.pptx
spillmanagement2q-220919041830-73be6d1d.pptxspillmanagement2q-220919041830-73be6d1d.pptx
spillmanagement2q-220919041830-73be6d1d.pptx
Monishabasavaraj
 
hospitalhousekeeping-161004115402.pdf
hospitalhousekeeping-161004115402.pdfhospitalhousekeeping-161004115402.pdf
hospitalhousekeeping-161004115402.pdf
Monishabasavaraj
 
medicolegalissues-151101050024-lva1-app6892.pdf
medicolegalissues-151101050024-lva1-app6892.pdfmedicolegalissues-151101050024-lva1-app6892.pdf
medicolegalissues-151101050024-lva1-app6892.pdf
Monishabasavaraj
 
dr-170826095415.pptx
dr-170826095415.pptxdr-170826095415.pptx
dr-170826095415.pptx
Monishabasavaraj
 
hospitallinenandlaundryservices-180509154222.pptx
hospitallinenandlaundryservices-180509154222.pptxhospitallinenandlaundryservices-180509154222.pptx
hospitallinenandlaundryservices-180509154222.pptx
Monishabasavaraj
 
CODE PINK copy.pptx
CODE PINK copy.pptxCODE PINK copy.pptx
CODE PINK copy.pptx
Monishabasavaraj
 
non-sporinganaerobes-160816140157.pptx
non-sporinganaerobes-160816140157.pptxnon-sporinganaerobes-160816140157.pptx
non-sporinganaerobes-160816140157.pptx
Monishabasavaraj
 
spillmanagement-181009192712.pptx
spillmanagement-181009192712.pptxspillmanagement-181009192712.pptx
spillmanagement-181009192712.pptx
Monishabasavaraj
 
finalmodule13environmentalcleaning2-230114032909-026182e8.pptx
finalmodule13environmentalcleaning2-230114032909-026182e8.pptxfinalmodule13environmentalcleaning2-230114032909-026182e8.pptx
finalmodule13environmentalcleaning2-230114032909-026182e8.pptx
Monishabasavaraj
 

More from Monishabasavaraj (20)

1. CODE BLUE MANAGEMNET.pptx
1. CODE BLUE MANAGEMNET.pptx1. CODE BLUE MANAGEMNET.pptx
1. CODE BLUE MANAGEMNET.pptx
 
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
1. POLICY ON GRIEVANCE & DICIPLINARY PROCEDURE.pptx
 
2. CPR.pptx
2. CPR.pptx2. CPR.pptx
2. CPR.pptx
 
STAFF PERSONAL RECORD copy.pptx
STAFF PERSONAL RECORD copy.pptxSTAFF PERSONAL RECORD copy.pptx
STAFF PERSONAL RECORD copy.pptx
 
SURGICAL SAFETY.pptx
SURGICAL SAFETY.pptxSURGICAL SAFETY.pptx
SURGICAL SAFETY.pptx
 
PREVENTION OF SEXUAL HARRASEMENT.pptx
PREVENTION OF SEXUAL HARRASEMENT.pptxPREVENTION OF SEXUAL HARRASEMENT.pptx
PREVENTION OF SEXUAL HARRASEMENT.pptx
 
drugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptxdrugrecallfinal-200423172250.pptx
drugrecallfinal-200423172250.pptx
 
VULNERABLE PATIENT.pptx
VULNERABLE PATIENT.pptxVULNERABLE PATIENT.pptx
VULNERABLE PATIENT.pptx
 
lookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptxlookalikeandsoundalikemedications-180319055839.pptx
lookalikeandsoundalikemedications-180319055839.pptx
 
PATIENT FEEDBACK.pptx
PATIENT FEEDBACK.pptxPATIENT FEEDBACK.pptx
PATIENT FEEDBACK.pptx
 
END OF LIFE CARE.pptx
END OF LIFE CARE.pptxEND OF LIFE CARE.pptx
END OF LIFE CARE.pptx
 
spillmanagement2q-220919041830-73be6d1d.pptx
spillmanagement2q-220919041830-73be6d1d.pptxspillmanagement2q-220919041830-73be6d1d.pptx
spillmanagement2q-220919041830-73be6d1d.pptx
 
hospitalhousekeeping-161004115402.pdf
hospitalhousekeeping-161004115402.pdfhospitalhousekeeping-161004115402.pdf
hospitalhousekeeping-161004115402.pdf
 
medicolegalissues-151101050024-lva1-app6892.pdf
medicolegalissues-151101050024-lva1-app6892.pdfmedicolegalissues-151101050024-lva1-app6892.pdf
medicolegalissues-151101050024-lva1-app6892.pdf
 
dr-170826095415.pptx
dr-170826095415.pptxdr-170826095415.pptx
dr-170826095415.pptx
 
hospitallinenandlaundryservices-180509154222.pptx
hospitallinenandlaundryservices-180509154222.pptxhospitallinenandlaundryservices-180509154222.pptx
hospitallinenandlaundryservices-180509154222.pptx
 
CODE PINK copy.pptx
CODE PINK copy.pptxCODE PINK copy.pptx
CODE PINK copy.pptx
 
non-sporinganaerobes-160816140157.pptx
non-sporinganaerobes-160816140157.pptxnon-sporinganaerobes-160816140157.pptx
non-sporinganaerobes-160816140157.pptx
 
spillmanagement-181009192712.pptx
spillmanagement-181009192712.pptxspillmanagement-181009192712.pptx
spillmanagement-181009192712.pptx
 
finalmodule13environmentalcleaning2-230114032909-026182e8.pptx
finalmodule13environmentalcleaning2-230114032909-026182e8.pptxfinalmodule13environmentalcleaning2-230114032909-026182e8.pptx
finalmodule13environmentalcleaning2-230114032909-026182e8.pptx
 

Recently uploaded

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 

Critical Alert.-2.pdf

  • 1. Critical Alerts in Laboratory Group :1 Dr. Pallavi Shukla Reviewed By : Dr. Sujith H. Dr. Lallu Joseph Mr. Govardan Dr. Uma Shankar Mr. Shankar Hiremat Ms. Jyothi Ramesh
  • 2. Defining Critical Value “Values that are outside normal range to a degree that may contribute on immediate health risk to individual or require immediate action on part of ordering physician”
  • 3. •Alert value: These are results that deviate from their reference ranges less significantly than critical values.
  • 4. Why is it so Important?? • To prevent imminent life threatening situation • Help clinicians redefining treatment plans • Failure to report poses a threat to patient safety and hospital quality • critical values communication is now an integral part of many accreditation procedures for medical laboratories like ISO,NABL • endorsed as one of the leading quality indicators of the post-analytical phase by International Federation of Clinical Chemistry and Laboratory Medicine (IFCC).
  • 5. Upper Limit Lower Limit Normal Range Value= 120mmol/L (potentialharm likely to occur:cerebraloedema) Value≤ 115mmol/Lorrapid reductionin sodium level (may lead tocomaor death) SerumSODIUM 135-145 mmol/L Value>145 mmol/L (hypernatremia) Value<135 mmol/L (hyponatremia) LOWERCRITICALV ALUE/RESUL T UPPERCRITICALV ALUE/RESUL T 125 mmol/L 155 mmol/L Value≥ 158-160mmol?l (potentialharm likely to occur:anorexia,muscle weakness,nausea,vomitting, lethargy and coma) Value≥ 160mmol/L (ass.with 75% mortalityin adult
  • 6. ANALYTE CRITICAL VALUE Haemoglobin Any age ≤7.0 g/dL Haematocrit (PCV) Any age ≤21.0 ≥65.0 % Potassium; ISTAT (POCT) Any age <3.0 >6.0 mmol/L pH Any age <7.20 >7.60 pH units Bicarbonate (Whole Blood) Any age <10 >40 mEq/L Troponin I Any age ≥0.3 ng/mL PT INR Any age >5.0 Clinical Biochemistry and Pathology
  • 7. Microbiology: Any Assay with positive bioterrorism agent. Serology. Any Clinically Important Positive Culture.
  • 8. • The Final Classification of a Laboratory result as “Critical” is based on • It’s Laboratory Values, as well. • As the Patient’s analytical history and • Any available Clinical Information. • Should be Communicated with 1 hour or asap. • 24X7
  • 9. Developing a Training Module • Policy Standard : The critical Laboratory Results should be intimidated immediately to the concerned personnel • Objective: To ensure all critical care results that need immediate attention by the treating clinicians are defined, documented, communicated in a defined time frame
  • 10. Pre Requisites • The Central Lab committee should identify and define critical results for all the tests performed in the lab in consensus with clinicians • The list to be displayed in the lab • regularly update the list as and when new tests are added • Relevant staff should be trained on critical values and the reporting process
  • 11. •Implementation Guidelines/Requirements: Target Personnel: Qualified lab personnel, Nursing staff, Doctors Training frequency: To be part of induction program and updated during on going training
  • 12. • Defining and identifying critical care results • Define and Identify pre analytical/analytical/post analytical errors prior to communication • Informing concerned lab consultant • Confirming Critical result • Communicating to concerned personnel (verbal/report dispatch/electronic modes) • Documentation(specific register and in case files) and Communication of critical results(for both inhouse and outsourced) • Performing Mock Drills
  • 13. • Sepsis (ABG, CBC, RFT, LFT, Cultures) • Uncontrolled Diabetes Mellitus (Blood sugars, Urine Ketones, ABG, RFT, Electrolytes) • Respiratory Failure (ABG) • Myocardial Infarction (Cardiac Enzymes) • Viral Fever(Platelet Count) • Acute Renal Failure (RFT, Electrolytes)
  • 14. LABORA TORYPROCEDUREFORNOTIFICA TIONOF CRITICALRESUL TS LABORATORY PERFORM TEST(ROUTINE / URGENT/STAT) VERIFY THE RESULT CHECK RECORD ANY CRITICAL LIMIT? REFER CRITICAL VALUE LIST DISPATCH A COPY OF RESULT TO WARD/A&E CHECK FOR TREND PHONE ELECTRONIC SMS MANUAL DISPATCH DOCUMENT THE NOTIFICATION AND RELEVANT INFORMATION INTO RECORD BOOK,LIS OR STANDARD NOTIFICATION STAFF NURSE SPECIALIST MO JM MA INFORM RESULT AND ASK FOR READ BACK FROM RECORD BOOK COMPARE WITH PREVIOUS RESULT WHAT TO INFORM? INFORMER NAME DESIGNATION PATIENT ID &LOCATION TEST NAME&RESULT SAMPLE DATE &TIME DIFFERENT TREND TO WHOM? HOW? SAME TREND REPEAT TEST CHECK FOR COMMON ANALYTICAL INTERFERENCE CHECK FOR PRE- ANALYTICAL, ANALYTICAL &POST ANALYTICAL FACTOR RECORD: INFORMER NAME & DESIGNATION PATIENT ID & WARD NAME TEST NAME & RESULT SAMPLE DATE & TIME RECIPIENT NAME
  • 15.
  • 16.
  • 17. WARD/CLINIC/A&EPROCEDUREFORNOTIFICA TIONOFLABORA TORYCRITICALRESUL T IF PATIENT HAS BEEN DISCHARGED RECORD IN NURSING NOTES/NURSING CARE PLAN/BHT MEDICAL ATTENTION BY DOCTOR IN-CHARGE READ BACK INFORMATION RECEIVED RECORD INFORMATION RECEIVED INFORM DOCTOR IMMEDIATELY CONTACT THE DOCTOR IN CHARGE IMMEDIATELY ATTACH RESULT IN BHT IF PATIENT TRANSFERRED OUT TO ANOTHER HOSPITAL/WARD TO READ BACK: PATIENT NAME & ID TEST NAME & RESULT RECEIPIENT OR SN IN CHARGE INFORM/FORWARD TO STAFF IN ANOTHER WARD MO/SPECIALIST IN CHARGE WILL DECIDE: CALL BACK PATIENT TO WARD/CLINIC BRING FORWARD APPOINTMENT DATE CALL PATIENT FOR EARLY APPOINTMENT THE DOCTOR HAS TO SIGN ON THE RESULT SLIP WRITE THE PLAN MANAGEMENT IN PATIENT’S BHT IN: STANDARD FORM PATIENT CASE NOTE (IMMEDIATELY DONE) BHT FOR IN-BHT OTHERS: i.e: STAMP WHAT TO RECORD? PATIENT NAME PATIENT RN,ID TEST NAME AND RESULT SAMPLE TIME AND DATE DATE AND TIME OF NOTIFICATION NAME OF INFORMER WARD STAFF RECEIVES CRITICAL RESULT NOTIFICATION FROM LAB VIA:  VERBALLY(PHONE) ELECTRONIC ALERT (THIS)  MANUAL DISPATCH OF RESULT  SMS  E-MAIL RESPONSIBLE STAFF: STAFF NURSE IN CHARGE MEDICAL ASSISTANT HO MO SPECIALIST
  • 18. QUICK GUIDE LABORATORY 1) IDENTIFY ANY CRITICAL RESULT 2) CONFIRM CRITICAL RESULT CHECK RESULT CHECK SAMPLE CHECK QC VERIFY CRITICAL RESULT 3) CALL WARD IMMEDIATELY 4) INFORM RESULT ASK FOR READ BACK 5) RECORD THE NOTIFICATION WARD 6) RECEIVE,RECORD AND READ BACK THE CLR 7) INFORM MO IMMEDIATELY 8)GET HARD COPY OF RESULT FROM LAB 9) ATTACH RESULTS IN BHT
  • 19. Monitoring • HCO to define schedule for assessing quality implementation of guidelines • Quality standards of the lab • Regular updating of the tests list • Can have mock drills and performance indicators to the staff • Trained staff can be asked to train other untrained personnel
  • 20. Evidences • HCO to have an Apex Manual with 1. the list of tests  their standard reference intervals and critical result values 2. instructions to the concerned personnel on communication and reporting